Biohaven Ltd. operates as a biopharmaceutical company that focuses on neurological and neuropsychiatric diseases. Its portfolio includes treatments for medical needs including focal epilepsy, obsessive compulsive disorder, spinocerebellar ataxia and spinal muscular atrophy. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is market cap of Biohaven Ltd?
The market cap of Biohaven Ltd is $882M
What is the 52 week high for Biohaven Ltd?
The 52 week high for Biohaven Ltd is $20.57.
What is the 52 week low for Biohaven Ltd?
The 52 week low for Biohaven Ltd is $5.54.
What is Biohaven Ltd stock price today?
Biohaven Ltd' stock price today is $14.29.
What is the price to book ratio of Biohaven Ltd?
The price to book ratio of Biohaven Ltd is 8.8010.
What is the 50-day moving average of Biohaven Ltd?
The 50-day moving average of Biohaven Ltd is 16.3744.